Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bloom

Showing results (861-870 of 990) with videos related to

Pageof 99
Sort By:
Cell|June 14, 2022
Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoproteinM Alejandra Tortorici, Alexandra C Walls, Anshu Joshi, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2009
Novel pyrazolopyrimidines as highly potent B-Raf inhibitorsMartin J Di Grandi, Dan M Berger, Darrin W Hopper, et al.
Journal of the American Society of Nephrology : JASN|March 22, 2017
Comparing Outcomes between Antibody Induction Therapies in Kidney TransplantationNeel Koyawala, Jeffrey H Silber, Paul R Rosenbaum, et al.
Plos Pathogens|April 5, 2014
Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza virusesJeff Butler, Kathryn A Hooper, Stephen Petrie, et al.
Plos Biology|November 12, 2024
Deep mutational scanning of H5 hemagglutinin to inform influenza virus surveillanceBernadeta Dadonaite, Jenny J Ahn, Jordan T Ort, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2023
Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infectionJamie Guenthoer, Michelle Lilly, Tyler N Starr, et al.
Nature|July 9, 2025
Loss of FCoV-23 spike domain 0 enhances fusogenicity and entry kineticsM Alejandra Tortorici, Annette Choi, Cecily A Gibson, et al.
The Journal of Infectious Diseases|February 3, 2021
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 InfectionKatharine H D Crawford, Adam S Dingens, Rachel Eguia, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Deep mutational scanning of H5 hemagglutinin to inform influenza virus surveillanceBernadeta Dadonaite, Jenny J Ahn, Jordan T Ort, et al.
Medrxiv : the Preprint Server for Health Sciences|February 4, 2022
Dynamics of infection-elicited SARS-CoV-2 antibodies in children over timeLauren E Gentles, Leanne Kehoe, Katharine H D Crawford, et al.
Pageof 99

Showing results (861-870 of 990) with videos related to

Sort By:
Pageof 99
Cell|June 14, 2022
Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoproteinM Alejandra Tortorici, Alexandra C Walls, Anshu Joshi, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2009
Novel pyrazolopyrimidines as highly potent B-Raf inhibitorsMartin J Di Grandi, Dan M Berger, Darrin W Hopper, et al.
Journal of the American Society of Nephrology : JASN|March 22, 2017
Comparing Outcomes between Antibody Induction Therapies in Kidney TransplantationNeel Koyawala, Jeffrey H Silber, Paul R Rosenbaum, et al.
Plos Pathogens|April 5, 2014
Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza virusesJeff Butler, Kathryn A Hooper, Stephen Petrie, et al.
Plos Biology|November 12, 2024
Deep mutational scanning of H5 hemagglutinin to inform influenza virus surveillanceBernadeta Dadonaite, Jenny J Ahn, Jordan T Ort, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2023
Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infectionJamie Guenthoer, Michelle Lilly, Tyler N Starr, et al.
Nature|July 9, 2025
Loss of FCoV-23 spike domain 0 enhances fusogenicity and entry kineticsM Alejandra Tortorici, Annette Choi, Cecily A Gibson, et al.
The Journal of Infectious Diseases|February 3, 2021
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 InfectionKatharine H D Crawford, Adam S Dingens, Rachel Eguia, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Deep mutational scanning of H5 hemagglutinin to inform influenza virus surveillanceBernadeta Dadonaite, Jenny J Ahn, Jordan T Ort, et al.
Medrxiv : the Preprint Server for Health Sciences|February 4, 2022
Dynamics of infection-elicited SARS-CoV-2 antibodies in children over timeLauren E Gentles, Leanne Kehoe, Katharine H D Crawford, et al.
Pageof 99